mol42
20 Jun 2018
RNS John Morley thx elrico direct link here from your post nutritioninsight.com/ SlimBiome muesli to hit UK shelves 20 Jun 2018 --- Fruit, nut and seed supplier John Morley are teaming up with OptiBiotix health to deliver a weight-management breakfast muesli utilizing the SlimBiome technology. OptiBiotix’s patented Slimbiome claims to support weight-loss... jees thought i was generally talking to myself on this new look website ( not only on this bb btw) - seems a number of regular posters, that i recognise on the old iii, have gone to pastures new don’t post anywhere else and have no intention of signing up anywhere else though bb on the new look here and elsewhere leaves a lot to be desired and not the most user friendly i live in hope that the usual old iii posters (those knowledgeable and reseachers!) will return as the old iii was generally one of the better sites to visit re bb discussion mol
elrico63
20 Jun 2018
RNS John Morley UK retail listing soon, is the hint.
mol42
18 Jun 2018
RNS John Morley happy days seems to post links from https need to put in [ ] brackets bw all mol
mol42
18 Jun 2018
RNS John Morley accounts can be found at companies house under john morley (importers) ltd holding company j m holdings ltd still cannot post direct link to companies house but presumably you all know how to search companies house if interested website John Morley John Morleys - UK Importers of Dried Fruit and Nuts We provide a wide range of ingredients from over 20 countries by our experienced team of experts - for bakers, breakfast cereal and food manufacturers. mol
mol42
18 Jun 2018
RNS John Morley Further agreement OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high high cholesterol, diabetes and skin care, announces it has entered into a manufacturing and supply agreement with John Morley Foods, (“Morleysâ€). The agreement grants Morleys an exclusive licence to manufacture and supply the SlimBiome® weight management technology in muesli packs within the UK, in return for 50% of the profit. Morleys is a private company and a leading supplier of high quality ingredients to breakfast cereal and food manufacturers including major retailers and many global consumer food brands. Morleys have invested substantive resource over the last six months in developing a range of muesli products containing SlimBiome® to be sold as own label products to major retailer or as product line extensions to existing well- known brands. SlimBiome®, a patented combination of natural ingredients developed by experts to provide hunger free weight loss, recently won the award for Weight Management of the Year at Vitafoods European trade show. Morleys will use their best endeavours to promote and expand the supply of SlimBiome® in muesli packs, bringing it to the attention of major retailers and branded cereal manufactures within the United Kingdom. The development of muesli breakfast products allows OptiBiotix to extend its GoFigureâ„¢ range of online products and create ‘health and wellbeing’ own label brands for supermarkets within the UK. This agreement, with one of the UK’s leading ingredient suppliers, is another step in expanding the range of products containing SlimBiome® to meet the needs of major UK retailers and the Iarge consumer markets of India and the USA. Stephen O’Hara, CEO of OptiBiotix, commented: “We are pleased to announce the signing of a manufacturing, supply and profit sharing agreement with Morleys. We chose Morleys due to their reputation as one of the UK’s leading suppliers of specialist ingredients and the energy and passion they have shown in developing a wide range of muesli products containing SlimBiome® over the last six months. We believe working with Morleys, and similar partners around the world, provides the best opportunity of meeting the requirements of major retailers and global brands who are looking to develop healthy products to meet growing consumer demand.†Simon Brown, Managing Director of John Morley Group added: “This is an exciting development, and a range like this has not been done by anyone else. Mueslis are healthy, but now we’re creating a muesli-plus, something that will help people control mid-morning snacking urges by making them feel fuller for longer. Not only that but SlimBiome®, as a prebiotic, is good for healthy gut bacteria. Our plan is to launch single serving muesli pots as well as the standard bagged format to target the individual market. We are delighted to be working with OptiBiotix and taking our relationship forward in new and exciting ways.†some reason cannot post link! mol
mol42
14 Jun 2018
Trades today LSE nexexchange |14/06/2018 16
7 |15,000 |65.38| |14/06/2018 15:50 |5,000 |65.38| |14/06/2018 15:23 |1,000 |65.4| |14/06/2018 14:29 |6,109 |65.47| |14/06/2018 12:26 |3,919 |64.1| |14/06/2018 12:13 |5,000 |65.6| |14/06/2018 12:13 |3,000 |64.1| |14/06/2018 11:49 |899 |65.6| |14/06/2018 11:37 |5,000 |65.6| |14/06/2018 10:27 |13,272 |65.47| |14/06/2018 10:27 |4,566 |65.47| |14/06/2018 09:17 |14,000 |64.33| |14/06/2018 08:49 |491 |65.8| |14/06/2018 08:24 |10,000 |64.33| |14/06/2018 08:12 |1,488 |66.8| |14/06/2018 08:12 |1,253 |65.1| |14/06/2018 08:10 |5,000 |65.3| |14/06/2018 086 |452 |65.3| mol
mol42
14 Jun 2018
Trades today LSE 176:33 14-Jun-2018 66.00 GBX 631,200 416,592.00 Off-book XOFF LRGS 16:25:11 14-Jun-2018 65.50 GBX 392,994 257,411.07 Off-book AIMX 15:557 14-Jun-2018 65.38 GBX 7,638 4,993.72 Off-book AIMX 15:420 14-Jun-2018 65.50 GBX 641,200 419,986.00 Off-book AIMX 15:26:14 14-Jun-2018 65.38 GBX 15,000 9,807.75 Off-book AIMX 14:469 14-Jun-2018 64.12 GBX 22,516 14,438.38 Off-book AIMX 14:37:43 14-Jun-2018 65.44 GBX 5,000 3,272.25 Off-book AIMX 14:273 14-Jun-2018 64.10 GBX 1,420 910.22 Off-book AIMX 13:14:46 14-Jun-2018 65.50 GBX 3,053 1,999.56 Off-book AIMX 12:39:22 14-Jun-2018 64.00 GBX 10,000 6,400.00 Off-book AIMX 12:304 14-Jun-2018 64.10 GBX 4,749 3,044.11 Off-book AIMX 11:19:14 14-Jun-2018 64.10 GBX 6,436 4,125.48 Off-book AIMX PRIC 11:15:14 14-Jun-2018 64.10 GBX 10,000 6,410.00 Off-book AIMX PRIC 10:34:42 14-Jun-2018 65.80 GBX 3,000 1,973.85 Off-book AIMX 10:25:10 14-Jun-2018 65.50 GBX 4,566 2,990.73 Off-book AIMX 105:26 14-Jun-2018 64.00 GBX 10,000 6,400.00 Off-book AIMX 104:45 14-Jun-2018 64.36 GBX 15,000 9,653.25 Off-book AIMX 09:21:13 14-Jun-2018 65.63 GBX 5,000 3,281.50 Off-book AIMX 08:54:19 14-Jun-2018 65.80 GBX 1,000 658.00 Off-book AIMX 08:50:12 14-Jun-2018 65.80 GBX 863 567.85 Off-book AIMX 08:19:58 14-Jun-2018 65.98 GBX 2,255 1,487.85 Off-book AIMX 08:17:28 14-Jun-2018 65.98 GBX 5,000 3,299.00 Off-book AIMX 08:140 14-Jun-2018 65.00 GBX 10,000 6,500.00 Off-book AIMX 081:38 14-Jun-2018 65.35 GBX 1,010 660.04 Off-book AIMX mol
mol42
13 Jun 2018
Probi AB link didn’t work as presumably too long in string length for ii site “[link] anyway you can all access from probi website mol
mol42
13 Jun 2018
Probi AB some discussion on other bbs re this company and Elrico mentioned in his article posted here so latest quarterly report [link] website Probi – 23 Jan 17 ABOUT PROBI PROBI IS A WORLD LEADER WITHIN PROBIOTICS - DEDICATED TO PROBIOTICS ONLY! where you can find annual accounts etc and this re agm Probi – 2 May 18 Probi´s Annual General Meeting 2018 On Probi´s Annual General Meeting on 2 May 2018 in Lund, the following was resolved: · The Annual General Meeting approved the Annual Report and resolved, in accordance with the Board’s proposal, that no dividend should be declared for the financial... remuneration discussed and approved - presumably if not approved not paid ceo presentation in swedish re agm but qtr1 results presentation here tv.streamfabriken.com Probi Q1 Report 2018 Q1 Report 2018 mol
mol42
13 Jun 2018
Pharmabiota [link] although all discussions to date transferred over as market discussions decided to use uk companies tag instead anyway just a bit of info but on sale now presumably mol
Popeye82
07 Jun 2018
US launch of LPLDL®, with Seed Health [link] launch of LPLDL® with Seed Health07 June 2018OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces the US launch of a product containing its cholesterol and blood pressure reducing strain LPLDL® with Seed Health ("Seed"
.OptiBiotix previously announced (RNS: 22 May 2018) that it has entered into a non-exclusive agreement with Seed to produce, promote, market and commercialise products containing LPLDL® in the USA. Seed will market its first product containing LPLDL® under the brand name Daily Synbiotic™ and promote it directly to consumers on its online platform www.seed.com.Seed was launched on 6 June 2018, with the aim of setting a new standard of scientific rigor and consumer education in the $38 billion global probiotics industry. Daily Synbiotic™, its first product, is targeted at the US probiotic market, one of the largest and fastest growing probiotic markets in the world, with supplements alone accounting for $2.06 billion sales, and a projected 55% growth per annum to $3.3 billion by 2021*.Seed's team is led by co-founders and co-CEOs, Ara Katz and Raja Dhir, and includes Chief Scientist, Dr. Gregor Reid, a pioneer in the field of probiotics. Seed's Scientific Advisory Board includes some of the world's leading microbiome scientists with expertise in microbiology, immunology, genetics, metabolomics, gastroenterology, paediatrics and women's health.*Market data from 'TRENDS, INNOVATIONS AND OPPORTUNITIES DRIVING THE GLOBAL PROBIOTICS MARKET' (Euromonitor International June 2017).Stephen O'Hara, CEO of OptiBiotix, commented: "We are excited to see the launch of products containing our cholesterol reducing LPLDL® strain in the USA, the world's largest and fastest growing probiotic market. The launch with Seed substantiates the science behind LPLDL® and helps build the LPLDL® brand in the consumer healthcare market around the world. We hope this will be the first of many product launches of multiple formulations and presentations of LPLDL® as the active component in a wide range of products in the USA and around the world." For further information, please contact:OptiBiotix Health plcStephen O´Hara, Chief Executive www.optibiotix.comContact via Walbrook below Cairn Financial Advisers LLPLiam Murray / Jo Turner Tel: 020 7213 0880 finnCap (Broker)Adrian Hargrave / Scott Mathieson / Kate Bannatyne (Corporate Finance)Abigail Wayne (Corporate Broking) Tel: 020 7220 0500 Walbrook PR LtdAnna Dunphy Tel: 020 7933 8780 or [email protected]: 07876 741 001 About OptiBiotix - www.optibiotix.comOptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits."
mol42
07 Jun 2018
Major shareholders I just like to keep an eye on said things - so have changed thread heading but kept threadwebsite updatedAs at 5 June 2018, the number of shares in issue was 82,905,067.Significant ShareholdersAs at 5 June 2018, significant shareholders that hold more than 3% of the share capital of OptiBiotix Health Plc, and shareholdings of any other directors are detailed below: Number Ordinary Shares %Stephen O'Hara (Director) 10,103,029 12.19Finance Yorkshire Seedcorn Fund (FYSCF) 9,449,314 11.40Stephen O'Hara holds 6,099,135 shares under OptionDirectors' Shareholders Number Ordinary Shares %Stephen O'Hara (Director) 10,103,029 12.19Neil Davidson (Director) 165,000 0.20Shares not in Public handsIn the terms of the AIM Rules and insofar as it is aware, at 5 June 2018, 23.79% of the Company's AIM securities was not in public hands.so no change re fyscf from 16 may to 5 jun presumably and as we know the new iis ,at time of placing, were below threshold disclosure - pity though not disclosedmol
mol42
06 Jun 2018
Re: Seed evening elricosource[link]
